Last reviewed · How we verify
PRP prolotherapy
At a glance
| Generic name | PRP prolotherapy |
|---|---|
| Sponsor | Abdelrahman Soliman Alateyh |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Comparison of Platelet-Rich Plasma and Prolotherapy for Plantar Fasciitis (NA)
- Survey-Based Study on Recovery Period Differences in Upper Extremity Injuries Among Indoor Climbers by Treatment Method
- Effects of Steroid, Dextrose Prolotherapy, and Platelet-Rich Plasma Injections in Knee Joint OA Patients (NA)
- Biotensegrity: Thoracolumbar Fascial Integrity in Chronic Low Back Pain
- The Effects of Platelet-Rich Plasma Versus Prolotherapy On Rotator Cuff Tendinopathy: A Randomized Controlled Trial. (PHASE1)
- High Frequency Intensive Autologous PRP Injection and Genicular Nerve Blocks in Treating Knee Osteoarthritis (NA)
- Platelet Rich Plasma and Neural Prolotherapy Injections in Treating Knee Osteoarthritis (NA)
- Efficacy of Injection Therapy for Lateral Epicondylosis (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- PRP prolotherapy CI brief — competitive landscape report
- PRP prolotherapy updates RSS · CI watch RSS
- Abdelrahman Soliman Alateyh portfolio CI